Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Cianchetti, M. Ledda (2011)
Effectiveness and safety of antipsychotics in early onset psychoses: A long-term comparisonPsychiatry Research, 189
A. Galuppi, M. Turola, M. Nanni, P. Mazzoni, L. Grassi (2010)
Schizophrenia and quality of life: how important are symptoms and functioning?International Journal of Mental Health Systems, 4
A. Ciudad, E. Álvarez, M. Bousoño, J. Olivares, J. Gómez (2007)
[Safety and tolerability of olanzapine versus risperidone: a one-year randomized study in outpatients with schizophrenia with prominent negative symptoms].Actas espanolas de psiquiatria, 35 2
O. Lingjærde, U. Ahlfors, P. Bech, S. Dencker, K. Elgen (1987)
The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patientsActa Psychiatrica Scandinavica, 76
A. Abi-Dargham, M. Laruelle (2005)
Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studiesEuropean Psychiatry, 20
M. Ritsner, Anatoly Gibel, Galina Perelroyzen, R. Kurs, Mahmoud Jabarin, Y. Ratner (2004)
Quality of Life Outcomes of Risperidone, Olanzapine, and Typical Antipsychotics Among Schizophrenia Patients Treated in Routine Clinical Practice: A Naturalistic Comparative StudyJournal of Clinical Psychopharmacology, 24
A. García‐Navarro, C. González-Puga, G. Escames, L. López, A. López, M. López-Cantarero, Encarnación Camacho, A. Espinosa, M. Gallo, D. Acuña-Castroviejo (2007)
Cellular mechanisms involved in the melatonin inhibition of HT‐29 human colon cancer cell proliferation in cultureJournal of Pineal Research, 43
G. Phillips, D. Brunt, S. Roychowdhury, Wen Xu, D. Naber (2006)
The relationship between quality of life and clinical efficacy from a randomized trial comparing olanzapine and ziprasidone.The Journal of clinical psychiatry, 67 9
A. Leão, Sônia Barros (2008)
As representações sociais dos profissionais de saúde mental acerca do modelo de atenção e as possibilidades de inclusão socialSaude E Sociedade, 17
Yang‐Tae Kim, B. Kang (2004)
A preliminary study of the comparative effects of olanzapine and risperidone on cognition in schizophreniaHuman Psychopharmacology: Clinical and Experimental, 19
P. Michalopoulou, S. Shergill, S. Kapur (2008)
New and old antipsychotics: what ‘effectiveness’ trials tell usPsychiatry MMC, 7
Y. Kao, Yia-Ping Liu, M. Chou, Tsung-Hsing Cheng (2011)
Subjective quality of life in patients with chronic schizophrenia: relationships between psychosocial and clinical characteristics.Comprehensive psychiatry, 52 2
P. Haddad, J. Hellewell, A. Wieck (2001)
Antipsychotic induced hyperprolactinaemia: a series of illustrative case reportsJournal of Psychopharmacology, 15
T. Stroup, J. Lieberman, J. McEvoy, M. Swartz, S. Davis, G. Capuano, R. Rosenheck, R. Keefe, Alexander Miller, Irving Belz, J. Hsiao (2007)
Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study.The American journal of psychiatry, 164 3
P. Seeman (2001)
Antipsychotic drugs, dopamine receptors, and schizophreniaClinical Neuroscience Research, 1
D. Human (1999)
Declaration of HelsinkiThe Lancet, 353
Yoshinori Ueoka, M. Tomotake, Tsunehiko Tanaka, Y. Kaneda, Kyoko Taniguchi, Masahito Nakataki, Shusuke Numata, Shin'ya Tayoshi, K. Yamauchi, Satsuki Sumitani, Takashi Ohmori, S. Ueno, T. Ohmori (2011)
Quality of life and cognitive dysfunction in people with schizophreniaProgress in Neuro-Psychopharmacology and Biological Psychiatry, 35
B. Carpiniello, G. Mellino, S. Pintore, L. Puddu, F. Pinna (2011)
[Effectiveness of antipsychotics in schizophrenia and related disorders. Results of a naturalistic study].La Clinica terapeutica, 162 4
S. Saarni, S. Pirkola (2010)
[Quality of life of psychiatric patients].Duodecim; laaketieteellinen aikakauskirja, 126 19
Yun Song, K. Kim, J. Park, Su Lee, J. Kang, Eun Lee, S. An, J. Kwon (2011)
Associated Factors of Quality of Life in First-Episode Schizophrenia PatientsPsychiatry Investigation, 8
CS Cardoso, M Bandeira, WT Caiaffa, JOP Fonseca (2002)
Escala de qualidade de vida para pacientes com esquizofrenia QLS-BR: Adaptação transcultural para o BrasilJornal Brasileiro de Psiquiatria, 51
D. Heinrichs, T. Hanlon, W. Carpenter (1984)
The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome.Schizophrenia bulletin, 10 3
T. Stroup, J. McEvoy, Kimberly Ring, R. Hamer, L. LaVange, M. Swartz, R. Rosenheck, D. Perkins, Abraham Nussbaum, J. Lieberman (2011)
A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP).The American journal of psychiatry, 168 9
G. Foussias, G. Remington (2010)
Antipsychotics and Schizophrenia: From Efficacy and Effectiveness to Clinical Decision-MakingThe Canadian Journal of Psychiatry, 55
L. Reichman, A. Fanning (2001)
Drug development for tuberculosis: the missing ingredientThe Lancet, 357
This cross-sectional study aimed to compare the effects of treatment with an atypical antipsychotic drug (olanzapine or risperidone) on quality of life (QoL) and to document adverse effects in 115 patients diagnosed with schizophrenia who attended the ambulatory service of Hospital Dr. João Machado, Natal, Rio Grande do Norte, Brazil. Socioeconomic, sociodemographic, and clinical variables were compared. The QoL Scale validated for Brazil (QLS-BR) was used to evaluate QoL, and adverse effects were assessed using the Udvalg for Kliniske Undersøgelser Side Effect Rating Scale. Data were analyzed using the χ2 test and Student’s t test, with a significance level of 5 %. Patients in both drug groups showed severe impairment in the occupational domain of the QLS-BR. Global QLS-BR scores indicated impairment among risperidone users and severe impairment among olanzapine users. The most significant side effects were associated with risperidone, including asthenia/lassitude/fatigue, somnolence/sedation, paresthesia, change in visual accommodation, increased salivation, diarrhea, orthostatic posture, palpitations/tachycardia, erythema, photosensitivity, weight loss, galactorrhea, decreased sexual desire, erectile/orgasmic dysfunction, vaginal dryness, headache, and physical dependence. QoL was impaired in patients using olanzapine and in those using risperidone. Risperidone use was associated with psychic, neurological, and autonomous adverse effects and other side effects.
Psychiatric Quarterly – Springer Journals
Published: Jul 18, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.